Radiopharm Theranostics Limited (ASX:RAD) Raises A$8 Million
Radiopharm raises A$8 million from Lantheus, increasing its shareholding to 12.16% to support the clinical pipeline.
The Hub of Australian Finance News
Radiopharm raises A$8 million from Lantheus, increasing its shareholding to 12.16% to support the clinical pipeline.
DigitalX Limited (ASX:DCC) announces significant treasury holdings and performance insights for December 2024.
AdAlta Limited (ASX:1AD) to present its advancements in cell therapeutics at Biotech Showcase 2025 during JPMorgan Healthcare Week.
URW has sold a 25% stake in Centrum Černý Most, reducing net debt and establishing a partnership for future growth.
Bailador Technology Investments Limited announces increased valuations for Updoc and Mosh, reflecting strong business performance.
Belararox Limited (ASX: BRX) updates its drilling plans at Malambo and Tambo South, focusing on safety and project timelines.
Briscoe Group Limited updates on trading performance and adjusts NPAT guidance amidst ongoing retail challenges.
Merchant House International Limited receives US$4.9 million from the sale of its 33.79% interest in Tianxing.
VRX Silica Limited receives a key EPA recommendation for the Arrowsmith North development project, marking a critical step in the environmental approval process.
Platinum Asset Management (ASX:PTM) reports growth in funds under management alongside notable net outflows in December 2024.